Replies to post #42554 on Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

As we cross the 2nd favorable safety landmark with aviptadil, we get closer to EUA. We now have 500 patients who are proof that aviptadil is safe.

EUA for HGEN-Lenzilumab (another covid therapeutic) was recently rejected based on 'safety' concerns.

Favorable efficacy of aviptadil has been well known for some time now.

As Dr Joey recently put it.... "it's not a matter of if, it's a matter of when".

https://finance.yahoo.com/news/nrx-pharmaceuticals-announces-second-favorable-104800032.html